Kezar Life Sciences, Inc.KZRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-74.24M
↓ 81% below average
Average (8y)
$-40.98M
Historical baseline
Range
High:$-8.50M
Low:$-83.45M
CAGR
+28.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-74.24M | +11.0% |
| 2023 | $-83.45M | -38.1% |
| 2022 | $-60.42M | -41.3% |
| 2021 | $-42.75M | -15.1% |
| 2020 | $-37.14M | -21.8% |
| 2019 | $-30.48M | -39.1% |
| 2018 | $-21.91M | -157.8% |
| 2017 | $-8.50M | +14.1% |
| 2016 | $-9.89M | - |